Skip to main content
Log in

Extrakorporale Membranoxygenierung beim akuten Lungenversagen

  • Intensivmedizin
  • Published:
Der Anaesthesist Aims and scope Submit manuscript

Zusammenfassung

Die extrakorporale Membranoxygenierung (ECMO) stellt heute im Rahmen klinischer Algorithmen einen wichtigen Baustein in der Therapie des schweren akuten Lungenversagens (ARDS) dar, nachdem sich in observationellen Studien der Wert dieses Verfahrens für die ARDS-Therapie trotz fehlender positiver kontrollierter Studien gezeigt hat. In spezialisierten Zentren wird bei Patienten mit drohender Hypoxie nach Anwendung verschiedener konservativer Therapieverfahren die ECMO unter Integration von Blutpumpen und künstlichen Membranlungen (Oxygenatoren) als Lungenersatzverfahren angewandt. Die Neuentwicklung von Oberflächenbeschichtungen, optimierten Oxygenatoren und miniaturisierten Blutpumpen sollte in der Zukunft sowohl die Hämokompatibilität steigern als auch die klinische Anwendung vereinfachen und komplikationsärmer machen. Die Entwicklung von Oxygenatoren mit deutlich niedrigeren Strömungswiderständen ermöglicht dabei die klinische Anwendung als pumpenloses, durch die arteriovenöse Druckdifferenz getriebenes Lungenunterstützungsverfahren (ECLA). Diese Neuentwicklungen könnten in der Zukunft zur Anwendung der ECMO nicht mehr nur als „ultima ratio“, sondern auch bei weniger schwerem ARDS führen, um lungenprotektivere, weniger invasive Beatmungsformen zu ermöglichen.

Abstract

After various observational studies demonstrated a benefit of extracorporeal membrane oxygenation (ECMO) in the therapy of severe acute respiratory distress syndrome (ARDS), ECMO now represents an important contribution for ARDS therapy using clinical algorithms despite a lack of positive controlled studies. In specialized centers patients with severe ARDS and imminent hypoxia despite intensive conventional therapy, are treated with ECMO using blood pumps and artificial membrane lungs (oxygenators) for extracorporeal lung assist. The development of new surface modifications, optimized oxygenators and miniaturized blood pumps should increase hemocompatibility and lead to simplified treatment as well as less complications. New oxygenators with significantly decreased blood resistance allow the clinical application of pumpless arteriovenous extracorporeal lung assist (ECLA). After these new developments indications for ECMO could be extended from use not only as ultima ratio but to less severe ARDS to enable lung protective, less invasive mechanical ventilation.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Abb. 1
Abb. 2
Abb. 3
Abb. 4
Abb. 5

Literatur

  1. Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308

    PubMed  Google Scholar 

  2. Ashbaugh DG, Bigelow DB, Petty TL, Levine BE (1967) Acute respiratory distress in adults. Lancet 2:319–323

    CAS  PubMed  Google Scholar 

  3. Bartlett RH, Gazzaniga AB, Jefferies MR, Huxtable RF, Haiduc NJ, Fong SW (1976) Extracorporeal membrane oxygenation (ECMO) cardiopulmonary support in infancy. Trans Am Soc Artif Intern Organs 22:80–93

    CAS  PubMed  Google Scholar 

  4. Bartlett RH, Roloff DW, Custer JR, Younger JG, Hirschl RB (2000) Extracorporeal life support: the University of Michigan experience. JAMA 283:904–908

    CAS  PubMed  Google Scholar 

  5. Beardsmore C, Dundas I, Poole K, Enock K, Stocks J (2000) Respiratory function in survivors of the United Kingdom extracorporeal membrane oxygenation trial. Am J Respir Crit Care Med 161:1129–1135

    CAS  PubMed  Google Scholar 

  6. Bernard GR, Artigas A, Brigham KL et al. (1994) The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149:818–824

    CAS  PubMed  Google Scholar 

  7. Bindslev L, Eklund J, Norlander O et al. (1987) Treatment of acute respiratory failure by extracorporeal carbon dioxide elimination performed with a surface heparinized artificial lung. Anesthesiology 67:117–120

    CAS  PubMed  Google Scholar 

  8. Brower RG, Matthay M, Schoenfeld D (2002) Meta-analysis of acute lung injury and acute respiratory distress syndrome trials. Am J Respir Crit Care Med 166:1515–1517

    Google Scholar 

  9. Clowes GH, Hopkins AL, Neville WE (1956) An artificial lung dependent upon diffusion of oxygen and carbon dioxide through plastic membranes. J Thorac Cardiovasc Surg 32:630–637

    Google Scholar 

  10. Conrad SA, Zwischenberger JB, Grier LR, Alpard SK, Bidani A (2001) Total extracorporeal arteriovenous carbon dioxide removal in acute respiratory failure: a phase I clinical study. Intensive Care Med 27:1340–1351

    Google Scholar 

  11. Dembinski R, Kopp R, Henzler D et al. (2003) Extracorporeal gas exchange with the Deltastream rotary blood pump in experimental lung injury. Artif Organs 27:530–536

    Article  CAS  PubMed  Google Scholar 

  12. Gattinoni L, Pesenti A, Mascheroni D et al. (1986) Low-frequency positive-pressure ventilation with extracorporeal CO2 removal in severe acute respiratory failure. JAMA 256:881–886

    CAS  PubMed  Google Scholar 

  13. Gibbon JH (1937) Artificial maintenance of circulation during experimental occlusion of pulmonary artery. Arch Surg 34:1105–1131

    Google Scholar 

  14. Hill JD, O’Brien TG, Murray JJ (1972) Prolonged extracorporeal oxygenation for acute post-traumatic respiratory failure (shock-lung syndrome). N Engl J Med 286:629–634

    Google Scholar 

  15. Kopp R, Kuhlen R, Max M, Rossaint R (2002) Evidence-based medicine in the therapy of the acute respiratory distress syndrome. Intensive Care Med 28:244–255

    Google Scholar 

  16. Lewandowski K (2000) Extracorporeal membrane oxygenation for severe acute respiratory failure. Crit Care 4:156–168

    Article  CAS  PubMed  Google Scholar 

  17. Lewandowski K (2001) Epidemiologie und Pathophysiologie des akuten Lungenversagens. Intensivmedizin 38:426–436

    Article  Google Scholar 

  18. Lewandowski K, Rossaint R, Pappert D et al. (1997) High survival rate in 122 ARDS patients managed according to a clinical algorithm including extracorporeal membrane oxygenation. Intensive Care Med 23:819–835

    CAS  PubMed  Google Scholar 

  19. Liebold A, Reng CM, Philipp A, Pfeifer M, Birnbaum DE (2000) Pumpless extracorporeal lung assist—experience with the first 20 cases. Eur J Cardiothorac Surg 17:608–613

    Article  CAS  PubMed  Google Scholar 

  20. Linden V, Palmer K, Reinhard J, Westman R, Ehren H, Granholm T, Frenckner B (2000) High survival in adult patients with acute respiratory distress syndrome treated by extracorporeal membrane oxygenation, minimal sedation, and pressure supported ventilation. Intensive Care Med 26:1630–1637

    PubMed  Google Scholar 

  21. Meinhardt JP, Quintel M (2003) Extrakorporale Membranoxygenierung (ECMO) im Erwachsenenalter. Intensivmedizin 39:694–706

    Article  Google Scholar 

  22. Mols G, Loop T, Hermle G, Buttler J, Huber B, Schubert J, Benzing A (2001) 10 Jahre Erfahrung mit extrakorporaler Membranoxygenierung. Anasthesiol Intensivmed Notfallmed Schmerzther 36:4–14

    Article  CAS  PubMed  Google Scholar 

  23. Morris AH, Wallace CJ, Menlove RL et al. (1994) Randomized clinical trial of pressure-controlled inverse ratio ventilation and extracorporeal CO2 removal for adult respiratory distress syndrome. Am J Respir Crit Care Med 149:295–305

    CAS  PubMed  Google Scholar 

  24. Pappert D, Rossaint R, Gerlach H, Falke KJ (1996) Extracorporeal membrane oxygenation. In: Evans TW, Haslett C (eds) ARDS Acute respiratory distress syndrome. Chapman & Hall, London, pp 425–437

  25. Peek GJ, Moore HM, Moore N, Sosnowski AW, Firmin RK (1997) Extracorporeal membrane oxygenation for adult respiratory failure. Chest 112:759–764

    CAS  PubMed  Google Scholar 

  26. Peek GJ, Killer HM, Reeves R, Sosnowski AW, Firmin RK (2002) Early experience with a polymethylpentene oxygenator for adult extracorporeal life support. ASAIO J 48:480–482

    Article  CAS  PubMed  Google Scholar 

  27. Philipp A, Foltan M, Gietl M et al. (2003) Interventionelle extrakorporale Lungenunterstützung (ILA) mittels arterio-venösem Shunt und einem neu entwickelten Low Resistance Lung Assist Device (LAD). Kardiotechnik 12:7–12

    Google Scholar 

  28. Reng M, Philipp A, Kaiser M, Pfeifer M, Gruene S, Schoelmerich J (2000) Pumpless extracorporeal lung assist and adult respiratory distress syndrome. Lancet 356:219–220

    Article  CAS  PubMed  Google Scholar 

  29. Rossaint R, Pappert D, Gerlach H, Lewandowski K, Keh D, Falke K (1997) Extracorporeal membrane oxygenation for transport of hypoxaemic patients with severe ARDS. Br J Anaesth 78:241–246

    CAS  PubMed  Google Scholar 

  30. UK-Collaborative ECMO Trial Group (1996) UK collaborative randomised trial of neonatal extracorporeal membrane oxygenation. Lancet 348:75–82

    PubMed  Google Scholar 

  31. Ullrich R, Lorber C, Roder G, Urak G, Faryniak B, Sladen RN, Germann P (1999) Controlled airway pressure therapy, nitric oxide inhalation, prone position, and extracorporeal membrane oxygenation (ECMO) as components of an integrated approach to ARDS. Anesthesiology 91:1577–1586

    CAS  PubMed  Google Scholar 

  32. Wendel HP, Ziemer G (1999) Coating techniques to improve the hemocompatibility of artificial devices used for extracorporeal circulation. Eur J Cardiothorac Surg 16:342–350

    Article  CAS  PubMed  Google Scholar 

  33. Zapol WM, Snider MT, Hill JD et al. (1979) Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 242:2193–2196

    CAS  PubMed  Google Scholar 

  34. Zwischenberger JB, Wang D, Lick SD, Deyo DJ, Alpard SK, Chambers SD (2002) The paracorporeal artificial lung improves 5-day outcomes from lethal smoke/burn-induced acute respiratory distress syndrome in sheep. Ann Thorac Surg 74:1011–1016

    Article  PubMed  Google Scholar 

Download references

Interessenkonflikt:

Keine Angaben

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Kopp.

Anhang: ARDS-Zentren mit der Möglichkeit der ECMO-Therapie

Anhang: ARDS-Zentren mit der Möglichkeit der ECMO-Therapie

  • Klinik für Anästhesiologie, Universitätsklinikum Aachen, Pauwelstraße 30, 52074 Aachen

  • Klinik für Anästhesiologie und operative Intensivmedizin, Charité, Campus Virchow-Klinikum, Augustenburger Platz 1, 13353 Berlin

  • Anästhesiologische Universitätsklinik Freiburg, Hugstetter Straße 55, 79106 Freiburg

  • Zentrum für Anästhesie, Rettungs- und Intensivmedizin der Georg August Universität, Robert-Koch-Str. 40, 37075 Göttingen

  • Klinik für Anästhesiologie und operative Intensivmedizin, Universitätsklinikum Mannheim, Theodor-Kutzer-Ufer 1–3, 68167 Mannheim

  • Abteilung für Anästhesie und Intensivtherapie, Klinikum der Philips-Universität, Baldingerstr. 1, 35043 Marburg/Lahn

  • Institut für Anästhesiologie, Klinikum Großhadern, Marchioninistr. 15, 81377 München

  • Universitätsklinik für Anästhesiologie und Intensivmedizin, AKH, Woehringer Gürtel 18–20, 1090 Wien

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kopp, R., Henzler, D., Dembinski, R. et al. Extrakorporale Membranoxygenierung beim akuten Lungenversagen. Anaesthesist 53, 168–174 (2004). https://doi.org/10.1007/s00101-003-0643-3

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00101-003-0643-3

Schlüsselwörter

Keywords

Navigation